Name
University of Phoenix
NSG/498 Senior Leadership Practicum
Prof. Name
Date
Methicillin-resistant Staphylococcus aureus (MRSA) can be effectively managed through a coordinated infection prevention and quality improvement strategy that combines surveillance, hand hygiene, appropriate use of personal protective equipment (PPE), staff education, environmental cleaning, appropriate patient precautions, and evidence-based clinical care. Healthcare organizations can further reduce MRSA transmission by continuously monitoring infection data, identifying gaps in practice, supporting healthcare professionals with adequate resources, and evaluating outcomes over time.
Methicillin-resistant Staphylococcus aureus, commonly called MRSA, is a strain of S. aureus that has developed resistance to several commonly used antibiotics, including methicillin and related beta-lactam antibiotics. MRSA can cause infections ranging from skin and soft-tissue infections to more serious conditions such as bloodstream infections, pneumonia, and surgical-site infections.
In healthcare environments, MRSA can spread through contact with infected or colonized individuals, contaminated hands, equipment, and surfaces. Patients who are hospitalized for extended periods or who have invasive devices, surgical wounds, or other risk factors may be particularly vulnerable to healthcare-associated MRSA infections.
The consequences of MRSA extend beyond the individual patient. Infections may contribute to longer hospital stays, increased treatment requirements, higher healthcare costs, and poorer patient outcomes. For this reason, MRSA prevention should be incorporated into an organization’s broader patient safety and infection prevention program.
A comprehensive MRSA management plan helps healthcare organizations reduce preventable infections while strengthening their overall culture of safety. Effective infection prevention can also improve staff adherence to clinical protocols and provide healthcare leaders with measurable information for quality improvement.
A successful MRSA program should aim to:
Reduce healthcare-associated MRSA transmission and infections.
Improve adherence to hand hygiene and standard infection prevention practices.
Ensure appropriate use of PPE and patient precautions.
Strengthen healthcare worker education and competency.
Identify MRSA trends through ongoing surveillance.
Improve patient safety and clinical outcomes.
Support antimicrobial stewardship and appropriate antibiotic use.
Promote a sustainable culture of quality improvement.
MRSA management should not depend on a single intervention. Healthcare organizations achieve better results when infection prevention measures are implemented as part of a coordinated, multidisciplinary program.
Surveillance is an essential component of MRSA prevention because it allows healthcare organizations to understand where infections are occurring and whether prevention strategies are working.
Infection prevention teams can monitor MRSA cases, infection rates, transmission patterns, and compliance with relevant prevention practices. Data should be reviewed regularly so that emerging problems can be identified before they become widespread.
Depending on the healthcare setting and organizational policy, surveillance may include monitoring:
MRSA colonization and infection trends.
Healthcare-associated MRSA infections.
Unit-specific infection rates.
Hand hygiene compliance.
Compliance with appropriate precautions.
Environmental cleaning performance.
Relevant patient outcomes.
Surveillance data should be communicated to clinical leaders and frontline healthcare professionals in a way that supports improvement rather than blame.
Hand hygiene remains one of the most important measures for preventing the transmission of infectious organisms in healthcare settings. Healthcare professionals should perform hand hygiene at appropriate points during patient care and after contact with potentially contaminated surfaces or equipment.
Healthcare organizations should make hand hygiene supplies readily accessible and provide ongoing education, observation, feedback, and reinforcement.
Standard precautions should be applied consistently to all patients, while additional precautions should be implemented when clinically indicated and according to current infection prevention guidance.
PPE helps protect healthcare professionals and patients when there is a risk of exposure to infectious material. Gloves and gowns may be required when caring for patients with MRSA, depending on the care activity and applicable transmission-based precautions.
Organizations should ensure that appropriate PPE is available where it is needed and that healthcare workers understand when and how to use it correctly.
Patient placement and transmission-based precautions should follow current facility policies and applicable infection prevention guidance. Decisions should account for the patient’s infection status, clinical condition, transmission risk, and healthcare environment.
MRSA can persist on contaminated surfaces and equipment, making environmental hygiene an important part of infection prevention.
High-touch surfaces and reusable medical equipment should be cleaned and disinfected according to organizational protocols and manufacturer instructions. Particular attention should be given to equipment that is shared between patients.
Effective environmental services programs should include appropriate products, staff training, adequate time and resources, and routine monitoring of cleaning practices.
Healthcare professionals need current, practical education about MRSA prevention and infection control. Education should address not only what healthcare workers are expected to do but also why the practices are important.
Training may cover hand hygiene, PPE use, patient precautions, equipment disinfection, environmental cleaning, antimicrobial stewardship, and procedures for reporting suspected or confirmed infections.
Competency assessments and regular refresher education can help maintain consistent performance over time.
MRSA management also requires responsible antibiotic use. Antimicrobial stewardship programs help healthcare professionals select antibiotics appropriately, use the correct dose and duration, and avoid unnecessary antimicrobial therapy.
Reducing inappropriate antibiotic exposure can help limit the development and spread of antimicrobial resistance while supporting better patient outcomes.
Healthcare leaders have an important role in creating the organizational conditions required for successful infection prevention. Leadership support should extend beyond approving policies. Leaders should provide adequate staffing, supplies, education, data systems, and accountability mechanisms.
Leaders can strengthen MRSA prevention by:
Establishing clear infection prevention goals.
Providing adequate PPE and hand hygiene supplies.
Supporting infection prevention professionals.
Reviewing MRSA surveillance data.
Encouraging interdisciplinary collaboration.
Communicating quality improvement results with staff.
Addressing barriers to compliance.
Recognizing teams and individuals who contribute to patient safety.
A strong safety culture encourages healthcare professionals to report problems, participate in improvement initiatives, and consistently follow evidence-based practices.
A structured implementation process helps healthcare organizations move from identifying a problem to measuring measurable improvement.
The project team should begin by presenting the MRSA management plan to hospital administrators and relevant clinical leaders. The discussion should explain the clinical problem, available evidence, proposed interventions, required resources, and expected outcomes.
Leadership involvement is particularly important when implementation requires changes to staffing, supplies, education, surveillance systems, or organizational procedures.
Before implementing new interventions, the organization should establish a baseline. The assessment should identify existing MRSA infection rates, current prevention practices, staff compliance, available resources, and potential barriers.
A baseline makes it possible to determine whether the intervention produces meaningful improvement.
MRSA prevention requires collaboration among nurses, physicians, infection prevention specialists, laboratory personnel, environmental services staff, quality improvement professionals, and organizational leaders.
Interdisciplinary collaboration helps ensure that prevention strategies are practical and consistently applied throughout the organization.
The organization can then implement the selected interventions based on identified gaps. These may include enhanced surveillance, staff education, hand hygiene improvement, environmental cleaning initiatives, appropriate patient precautions, and antimicrobial stewardship activities.
Interventions should be clearly communicated to staff, supported with adequate resources, and incorporated into routine workflows whenever possible.
Implementation should be followed by regular monitoring. If compliance remains low or MRSA rates do not improve, the project team should investigate the reasons and modify the intervention as necessary.
Continuous quality improvement is more effective than treating MRSA prevention as a one-time project.
A successful MRSA management plan should use both process and outcome measures. MRSA infection rates alone may not explain why an intervention succeeds or fails.
Potential KPIs include:
MRSA infection rates per appropriate patient-days or other standardized denominator.
MRSA bloodstream infection rates.
Hand hygiene compliance.
Compliance with applicable transmission-based precautions.
Staff participation in MRSA education.
Environmental cleaning compliance.
Timeliness and completeness of surveillance reporting.
Appropriate antimicrobial use.
Patient outcomes associated with MRSA infection.
The organization should select measures that are appropriate for its healthcare setting and establish a consistent method for collecting and analyzing data.
A well-designed MRSA prevention program can produce benefits at multiple levels of the healthcare organization.
Healthcare leaders should gain better visibility into MRSA trends and infection prevention performance. Reliable surveillance data can support resource allocation, accountability, and long-term quality improvement.
Healthcare professionals should have improved access to education, evidence-based protocols, PPE, and infection prevention resources. Consistent support can improve adherence to recommended practices and strengthen interdisciplinary teamwork.
The primary patient-centered goal is to reduce preventable MRSA transmission and infection. Improved infection prevention can contribute to safer care, better outcomes, and reduced complications associated with healthcare-associated infections.
Resource requirements will vary according to the size of the healthcare organization and the scope of the project. The proposed two-month project can use a small multidisciplinary team supported by existing organizational resources.
| Team Member | Responsibility | Proposed Budget |
|---|---|---|
| Team Leader | Coordinate the project and communicate with leadership | $3,000 |
| Assistant Leader | Support implementation and monitoring activities | $200 |
| Treasurer | Manage project-related budgeting | $300 |
| Three Team Members | Collaborate with infection prevention and clinical staff | $1,000 |
| Total | $4,500 |
The budget should be treated as a planning estimate rather than a universal cost. Actual costs will depend on organizational staffing, existing technology, educational resources, PPE availability, and surveillance infrastructure.
Implementation may require access to:
Computers or laptops.
Smartphones or approved communication devices.
Internet and organizational information systems.
Hospital-approved PPE.
Infection surveillance and reporting systems.
Communication and educational software.
Existing hospital infrastructure should be used whenever possible to reduce unnecessary costs.
The project can be organized into four major milestones over approximately eight weeks.
During the initial phase, the project team establishes communication with hospital leadership, infection prevention professionals, and clinical departments. Baseline information and implementation priorities are identified.
The team introduces the selected MRSA monitoring and infection prevention interventions and ensures that healthcare professionals have the necessary resources and education.
The team evaluates staff compliance, resource availability, surveillance performance, and early patient safety outcomes.
At the end of the implementation period, the team reviews MRSA infection data and other selected indicators to determine whether measurable improvement occurred.
Because infection rates can fluctuate over time, organizations should avoid interpreting a short-term change in MRSA cases in isolation. Longer-term monitoring can provide a more reliable assessment of sustainability.
Continuous monitoring allows the project team to determine whether implementation is occurring as planned and whether the intervention is producing meaningful results.
Monitoring activities may include daily implementation logs, weekly performance reviews, compliance audits, surveillance reports, staff feedback, and patient outcome measurements.
Formative evaluation focuses on implementation. It determines whether the intervention is being delivered as intended and identifies barriers that need to be addressed.
Examples include evaluating:
Staff participation in education.
Availability of PPE and other supplies.
Compliance with infection prevention procedures.
Effectiveness of surveillance processes.
Staff understanding of MRSA protocols.
Summative evaluation examines the overall results of the project. The evaluation should compare outcomes with baseline measurements and determine whether the selected goals were achieved.
Important outcome measures may include changes in MRSA infection rates, patient outcomes, infection prevention compliance, and organizational performance.
Several factors can interfere with successful implementation. Common challenges include inadequate resources, inconsistent staff engagement, communication problems, competing organizational priorities, and limited leadership support.
Risk can be reduced through early stakeholder involvement, clear communication, regular performance reviews, appropriate resource allocation, and rapid response to identified barriers.
Healthcare leaders should also avoid relying solely on punitive approaches to compliance. A supportive quality improvement culture can encourage staff to identify obstacles and participate in developing practical solutions.
The Iowa Model Revised provides a structured approach for integrating evidence into clinical practice. It can be used to guide a MRSA quality improvement project from problem identification through implementation and evaluation.
The model encourages healthcare teams to identify a clinical or organizational problem, develop an answerable question, review relevant evidence, determine whether a practice change is appropriate, implement the change, and evaluate outcomes.
For a MRSA project, the model can help the team:
Identify MRSA transmission or infection as a clinical priority.
Develop a focused PICOT question when appropriate.
Search for current and credible evidence.
Evaluate the strength and relevance of available evidence.
Select appropriate evidence-based interventions.
Implement the practice change.
Monitor patient and process outcomes.
Determine whether the change should be sustained, modified, or expanded.
Using an evidence-based practice framework helps ensure that MRSA interventions are not selected solely because they are familiar or convenient. Instead, interventions are connected to available evidence, organizational needs, clinical expertise, and patient considerations.
During the early implementation period, the organization should focus on whether the necessary infrastructure and practices are in place. Expected short-term outcomes include functioning surveillance systems, availability of infection prevention supplies, completion of staff education, and improved adherence to relevant protocols.
Long-term evaluation should focus on whether improvements are sustained. Potential outcomes include reduced healthcare-associated MRSA infections, improved patient safety, stronger infection prevention practices, and continued staff adherence.
Sustainability requires ongoing leadership support, surveillance, education, feedback, and integration of successful practices into organizational policy and routine clinical workflows.
MRSA prevention is most effective when healthcare organizations combine surveillance, infection prevention, staff education, environmental hygiene, appropriate precautions, antimicrobial stewardship, and leadership support.
Continuous surveillance helps healthcare organizations identify infection trends and evaluate whether prevention interventions are working. Healthcare leaders also play a central role by providing resources, supporting frontline staff, and establishing a culture in which patient safety and evidence-based practice are organizational priorities.
The Iowa Model Revised can provide a systematic framework for translating evidence into practice and evaluating whether a MRSA quality improvement intervention produces measurable results.
MRSA stands for methicillin-resistant Staphylococcus aureus. It is a type of S. aureus bacteria that is resistant to several antibiotics commonly used to treat staphylococcal infections. MRSA can cause both community-associated and healthcare-associated infections.
Hospitals can reduce MRSA transmission by consistently applying hand hygiene and standard precautions, using appropriate transmission-based precautions when indicated, cleaning and disinfecting equipment and environmental surfaces, educating healthcare workers, monitoring infection trends, and supporting appropriate antimicrobial use.
MRSA surveillance provides healthcare organizations with data about infection patterns and prevention performance. Monitoring allows infection prevention teams to identify trends, evaluate interventions, detect potential transmission problems, and guide quality improvement.
Yes. Appropriate hand hygiene is a fundamental component of healthcare-associated infection prevention and helps reduce the transfer of microorganisms between patients, healthcare workers, and contaminated surfaces.
PPE helps protect healthcare workers and patients from exposure to infectious material. The type of PPE required depends on the patient’s condition, the care activity, and the applicable infection prevention precautions.
Antimicrobial stewardship promotes appropriate antibiotic selection, dosing, route, and duration. Responsible antibiotic use helps improve patient care and reduce unnecessary antimicrobial exposure that can contribute to antimicrobial resistance.
Important indicators include MRSA infection rates, MRSA bloodstream infection rates where applicable, hand hygiene compliance, adherence to relevant precautions, staff education participation, environmental cleaning performance, appropriate antimicrobial use, and patient outcomes.
Yes. The Iowa Model Revised can provide a structured evidence-based practice framework for identifying a clinical problem, reviewing evidence, implementing a practice change, and evaluating outcomes. It can therefore support a structured MRSA prevention and quality improvement initiative.
Centers for Disease Control and Prevention. (2025). Methicillin-resistant Staphylococcus aureus (MRSA).
https://www.cdc.gov/mrsa/
Centers for Disease Control and Prevention. (2024). Strategies for preventing MRSA in acute care facilities.
https://www.cdc.gov/healthcare-associated-infections/
Centers for Disease Control and Prevention. (2024). Core infection prevention and control practices for safe healthcare delivery in all settings.
https://www.cdc.gov/infection-control/hcp/core-practices/
Hanrahan, K., Fowler, C., & McCarthy, A. M. (2019). Iowa Model Revised: Research and evidence-based practice application. Journal of Pediatric Nursing, 48, 121–122.
https://doi.org/10.1016/j.pedn.2019.04.023
World Health Organization. (2024). Antimicrobial resistance.
https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
World Health Organization. (2022). Global report on infection prevention and control.
https://www.who.int/publications/i/item/9789240051164
Society for Healthcare Epidemiology of America. (2022). Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute-care hospitals: 2022 update. Infection Control & Hospital Epidemiology.
https://doi.org/10.1017/ice.2022.87
Agency for Healthcare Research and Quality. (2023). Patient safety primers: Methicillin-resistant Staphylococcus aureus (MRSA).
https://psnet.ahrq.gov/
